Nasdaq - Delayed Quote
USD
T. Rowe Price Health Sciences I (THISX)
101.13
+2.16
(+2.18%)
At close: 8:04:38 PM EDT
Performance Overview
| Morningstar Return Rating | -- |
| YTD Return | 18.20% |
|---|---|
| 5y Average Return | 4.90% |
| Number of Years Up | 8 |
| Number of Years Down | 1 |
| Best 1Y Total Return (Oct 28, 2026) | 30.27% |
| Worst 1Y Total Return (Oct 28, 2026) | -- |
| Best 3Y Total Return | 30.27% |
| Worst 3Y Total Return | -2.56% |
Trailing Returns (%) Vs. Benchmarks
Monthly Total Returns
THISX
Category
- YTD
- 12.96%
- 7.95%
- 1-Month
- -0.87%
- 4.81%
- 3-Month
- 5.23%
- 7.18%
- 1-Year
- 30.45%
- 30.16%
- 3-Year
- 13.57%
- 16.10%
- 5-Year
- 4.70%
- 15.71%
- 10-Year
- 11.26%
- 15.27%
- Last Bull Market
- 17.58%
- 23.06%
- Last Bear Market
- -9.86%
- -13.88%
Annual Total Return (%) History
Year
THISX
Category
Past Quarterly Returns
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
|
2026
|
-6.20% | 14.44% | 5.23% | -- |
|
2025
|
0.00% | -2.82% | 5.05% | 15.48% |
|
2024
|
7.98% | 0.02% | 5.94% | -10.90% |
|
2023
|
-2.27% | 3.47% | -5.41% | 7.91% |
|
2022
|
-8.56% | -9.86% | -2.02% | 8.86% |
|
2021
|
-0.25% | 9.84% | 1.35% | 2.13% |
|
2020
|
-13.39% | 23.51% | 6.88% | 13.94% |
|
2019
|
15.54% | 1.77% | -7.64% | 19.01% |
|
2018
|
1.38% | 6.35% | 11.60% | -15.78% |
|
2017
|
11.29% | 7.47% | 5.32% | 1.68% |
Rank in Category (By Total Return)
| YTD | 45 |
| 1-Month | 33 |
|---|---|
| 3-Month | 39 |
| 1-Year | 40 |
| 3-Year | 52 |
| 5-Year | 58 |
Load Adjusted Returns
| 1-Year | 30.45% |
| 3-Year | 13.57% |
|---|---|
| 5-Year | 4.70% |
| 10-Year | 11.26% |
Performance & Risk
| YTD Return | 18.20% |
| 5y Average Return | 4.90% |
| Rank in Category (ytd) | 45 |
| % Rank in Category (ytd) | -- |
| Beta (5Y Monthly) | 0.62 |
| Morningstar Risk Rating |
Fund Overview
| Category | Health |
| Fund Family | T. Rowe Price |
| Net Assets | 12.24B |
| YTD Return | 12.96% |
| Yield | 0.25% |
| Morningstar Rating | |
| Inception Date | Dec 29, 1995 |
Fund Summary
The fund normally invests at least 80% of its net assets (including any borrowings for investment purposes) in the common stocks of companies engaged in the research, development, production, or distribution of products or services related to health care, medicine, or the life sciences (collectively termed "health sciences"). While the fund can invest in companies of any size, the majority of fund assets are expected to be invested in large- and mid-capitalization companies. It is non-diversified.
